Onconetix Inc

Onconetix insider moves: HRT Financial’s buying‑sell flips hint at a bullish strategy amid a steep drop, offering clues for investors watching its oncology pipeline.

HRT Financial’s surge in Onconetix shares amid a steep price collapse signals insider confidence—and a potential turnaround—yet investors must weigh biotech risks and pending clinical data before buying.